What’s In Store for Hospital M&A in 2025?

This year will likely see a high rate of divesture among hospital M&A deals, according to Anu Singh, managing director at Kaufman Hall. He also predicted that health systems will continue to pursue partnerships with a broader array of organizations, such as payers and venture firms, to solve challenges. The post What’s In Store for…

Read More

How Unaffordable is Health Care?

In his latest JAMA Forum column, KFF’s Larry Levitt explores how unaffordable health care is in the U.S. in the context of the debate over extending enhanced Affordable Care Act premium tax credits and an upcoming election where affordability will likely be front and center.

Read More

BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs

Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public by merging with a Cormorant-sponsored SPAC. The combined company will continue developing drugs targeting various forms of mutated KRAS proteins that drive cancers. The post BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs appeared…

Read More

Why don’t patients price shop for healthcare?

Stuart Figueroa provides some insights in his Incidental Economist article: To start, price shopping is inconvenient. It requires the consumer to invest time and energy in finding a provider, oftentimes having to navigate provider directories that are inaccurate, incomplete, or outdated. Price shopping is also hampered by the mere fact that health insurance is complicated and…

Read More